Changes in serotonin(2A) and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex

Journal of Neurochemistry

Volumn 72, Issue 4, 1999, Pages 1593-1599

  Dean, Brian ^a   Hussain, Tabasum ^a   Hayes, Wendy ^a   Scarr, Elizabeth ^a   Kitsoulis, Susie ^a   Hill, Christine ^a   Opeskin, Kenneth ^a   Copolov, David L ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Dopamine receptors; Dorsolateral prefrontal cortex; GABA(A) receptors; Nitric oxide synthase; Schizophrenia; Serotonin(2A) receptor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOPAMINE; NITRIC OXIDE SYNTHASE; SEROTONIN 2A RECEPTOR; 1 (1 (2 THIENYL)CYCLOHEXYL)PIPERIDINE; 1-(1-(2-THIENYL)CYCLOHEXYL)PIPERIDINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR; DRUG DERIVATIVE; KETANSERIN; PHENCYCLIDINE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; TRITIUM;

4 AMINOBUTYRIC ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LIGAND BINDING; NEUROCHEMISTRY; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR DENSITY; SCHIZOPHRENIA; SEROTONIN UPTAKE; ADULT; AGED; BINDING COMPETITION; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; FEMALE; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; RADIOASSAY;

ADULT; AGED; AGED, 80 AND OVER; BINDING, COMPETITIVE; FEMALE; HUMANS; KETANSERIN; MALE; MIDDLE AGED; NEURONS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE SYNTHASE; PHENCYCLIDINE; PREFRONTAL CORTEX; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE; RECEPTORS, GABA-A; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; TRITIUM;

EID: 0032586747     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.721593.x     Document Type: Article

References (46)

1. Akbarian S., Vinuela A., Kim J. J., Potkin S. G., Bunney W. E., and Jones E. G. (1994) Distorted disturbance of nicotinamide adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalies in cortical development. Arch. Gen. Psychiatry 50, 178-187.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. 3rd edit., revised. American Psychiatric Association, Washington, D.C.
3. Arora R. C. and Meltzer H. Y. (1991) Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J. Neurol Transm. Gen. Sect. 85, 19-29.
4. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75, 1021-1031.
5. Bennett J. P., Enna S. J., Bylund D. B., Gillin J. C., Wyatt R. J., and Snyder S. H. (1979) Neurotransmitter receptors in frontal cortex of schizophrenics. Arch. Gen. Psychiatry 36, 927-934.
6. Bernstein H. G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., Falkai P., and Bogerts B. (1998) Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83, 867-875.
7. 2A receptor antagonists inhibit potassium-stimulated gamma-aminobutyric acid release in rat frontal cortex. Eur. J. Pharmacol. 309, 25-31.
8. Dean B. and Hayes W. (1996) Decreased frontal cortical serotonin2A receptors in subjects with schizophrenia. Schizophr. Res. 21, 133-139.
9. 3H]Raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects. Neuropharmacology 36, 779-786.
10. Dodd P. R., Thomas G. J., Harper C. G., and Kril J. J. (1992) Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver. J. Neurochem. 59, 1506-1515.
11. G-nitro-L-arginine labelling to measure cerebellar nitric oxide synthase in patients with schizophrenia. Neurosci. Lett. 202, 49-52.
12. Egan M. F. and Weinberger D. R. (1997) Neurobiology of schizophrenia. Curr. Opin. Neurobiol. 7, 701-707.
13. Foster P. (1998) Neuroleptic equivalence. Pharmaceut. J. 243, 431-432.
14. Fuster J. M. (1989) The Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe. Raven Press, New York.
15. Goldman-Rakic P. S. and Selemon L. D. (1997) Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23, 437-458.
16. A receptor binding in the prefrontal cortex following exposure to chronic stress. Brain Res. 684, 112-114.
17. Gurevich E. V. and Joyce J. N. (1997) Alterations in the cortical serotonergic system in schizophrenia: a postmortem study. Biol. Psychiatry 42, 529-545.
18. Hall H., Sedvall G., Magnusson O., Kopp J., Halldin C., and Farde L. (1994) Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11, 245-256.
19. 3H]Muscimol binding in autopsied brains of chronic schizophrenics. Life Sci. 40, 259-266.
20. Hashimoto T., Kitamura N., Kajimoto Y., Shirai Y., Shirakawa O., Mita T., Nishino N., and Tanaka C. (1993) Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia. Psychopharmacology (Berl.) 112 (Suppl.), S35-S39.
21. Helmeste D. M., Tang S. W., Bunney W. E. Jr., Potkin S. G., and Jones E. G. (1996) Decrease in σ but no increase in striatal dopamine D4 sites in schizophrenic brains. Eur. J. Pharmacol. 314, R3-R5.
22. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res. 648, 222-228.
23. Hill C., Keks N. A., Roberts S., Opeskin K., Dean B., and Copolov D. L. (1996a) Postmortem brain studies in schizophrenia: the problems of diagnosis. Am. J. Psychiatry 153, 533-537.
24. Hill C., Roberts S., Keks N. A., Dean B., Mackinnon A., and Copolov D. L. (1996b) Diagnostic Instrument for Brain Studies. Mental Health Research Institute, Melbourne.
25. Ishimaru M., Kurumaji A., and Toru M. (1992) NMDA-associated glycine binding site increases in schizophrenic brain. Biol. Psychiatry 32, 379-380.
26. 3H]Mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes. Eur. J. Pharmacol. 90, 461-462.
27. Joyce J. N., Shane A., Lexow N., Winokur A., Casanova M. F., and Kleinman J. E. (1993) Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8, 315-336.
28. Kingsbury A. E., Foster O. J., Nisbet A. P., Cairns N., Bray L., Eve D. J., Lees A. J., and Marsden C. D. (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol. Brain Res. 28, 318.
29. Knable M. B. and Weinberger D. R. (1997) Dopamine, the prefrontal cortex and schizophrenia. J. Psychopharmacol. 11, 123-131.
30. Knable M. B., Hyde T. M., Murray A. M., Herman M. M., and Kleinman J. E. (1996) A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls. Biol. Psychiatry 40, 1191-1199.
31. 3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J. Neural Transm. Gen. Sect. 77, 231-236.
32. Lahti R. A., Roberts R. C., and Tamminga C. A. (1995) D2-family receptor distribution in human postmortem tissue: an autoradiographic study. Neuroreport 6, 2505-2512.
33. 3H-ligand for serotonin S2 receptor binding sites. Mol. Pharmacol. 21, 301-314.
34. Lin A. M.-Y., Kao L.-S., and Chai C. Y. (1995) Involvement of nitric-oxide in dopaminergic transmission in rat striatum: an in vivo electrochemical study. J. Neurochem. 65, 2043-2049.
35. Lorrain D. S. and Hull E. M. (1993) Nitric oxide increases dopamine and serotonin release in medial preoptic area. Neuroreport 5, 87-89.
36. A-receptor subtypes really occur in the brain. Trends Neurosci. 19, 139-143.
37. Meltzer H. Y. (1987) Biological studies in schizophrenia. Schizophr. Bull. 13, 77-107.
38. Mita T., Hanada S., Nishino N., Kuno T., Nakai H., Yamadori Y., and Tanaka C. (1986) Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol. Psychiatry 21, 1407-1414.
39. Murray A. M., Hyde T. M., Knable M. B., Herman M. M., Bigelow L. B., Carter J. M., Weinberger D. R., and Kleinman J. E. (1995) Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J. Neurosci. 15, 2186-2191.
40. 3H]GABA release from cerebral cortical neurons is mediated by peroxynitrite. J. Neurochem. 65, 1109-1114.
41. Pandey G. N., Conley R. R., Pandey S. C., Goel S., Roberts R. C., Tamminga C. A., Chute D., and Smialek J. (1997) Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects. Psychiatry Res. 71, 137-149.
42. Seeman P., Guan H.-C., and Van Tol H. H. M. (1993) Dopamine D4 receptors elevated in schizophrenia. Nature 365, 441-445.
43. Simpson M. D. C., Slater P., Royston M. C., and Deakin J. F. W. (1992) Alterations in phencyclidine and sigma binding sites in schizophrenic brain. Schizophr. Res. 6, 41-48.
44. 3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses? Neurochem. Res. 18, 219-223.
45. 3H]TCP: a new tool with high affinity for the PCP receptor in rat brain. Brain Res. 280, 194-197.
46. Whitaker P. M., Crow T. J., and Ferrier I. N. (1981) Tritiated LSD binding in frontal cortex in schizophrenia. Arch. Gen. Psychiatry 38, 278-280.